Evidence map›Paper›PMID 25799054›Full record

ReviewNutrition research (New York, N.Y.)2015

Dietary amelioration of Helicobacter infection.

Jed W Fahey, Katherine K Stephenson, Alison J Wallace

Abstract readReview
In one paragraph

Review in Nutrition research (New York, N.Y.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Review
  3. Daily dietary patterns associated withFrontiers in nutrition · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Observational
  12. Management of multi-drug resistantGastroenterology and hepatology from bed to bench · 2017
    Review
  13. Association ofJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2017
    Article
  14. Article
  15. Article
  16. Diet andPrzeglad gastroenterologiczny · 2016
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jed W FaheyLewis B. and Dorothy Cullman Chemoprotection Center, Department of Pharmacology & Molecular Sciences, School of Medicine, Johns Hopkins University, Baltimore, MD, USA; Center for Human Nutrition, Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. Electronic address: jfahey@jhmi.edu.
Katherine K StephensonLewis B. and Dorothy Cullman Chemoprotection Center, Department of Pharmacology & Molecular Sciences, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Alison J WallaceNew Zealand Institute for Plant and Food Research Limited, Lincoln, New Zealand.

Funding

Isolation &Evaluation of Anticarcinogenic GlucosinolateR01CA093780 · NCI · JOHNS HOPKINS UNIVERSITY · PI TALALAY, PAUL · 2002 to 2011
$2.9M
NCI NIH HHS CA 93780-03NCI NIH HHS R01 CA093780
6 · The paper itself

Abstract

We review herein the basis for using dietary components to treat and/or prevent Helicobacter pylori infection, with emphasis on (a) work reported in the last decade, (b) dietary components for which there is mechanism-based plausibility, and (c) components for which clinical results on H pylori amelioration are available. There is evidence that a diet-based treatment may reduce the levels and/or the virulence of H pylori colonization without completely eradicating the organism in treated individuals. This concept was endorsed a decade ago by the participants in a small international consensus conference held in Honolulu, Hawaii, USA, and interest in such a diet-based approach has increased dramatically since then. This approach is attractive in terms of cost, treatment, tolerability, and cultural acceptability. This review, therefore, highlights specific foods, food components, and food products, grouped as follows: bee products (eg, honey and propolis); probiotics; dairy products; vegetables; fruits; oils; essential oils; and herbs, spices, and other plants. A discussion of the small number of clinical studies that are available is supplemented by supportive in vitro and animal studies. This very large body of in vitro and preclinical evidence must now be followed up with rationally designed, unambiguous human trials.

Indexed as

Dairy ProductsHoneyOils, VolatilePlants, EdibleProbioticsAnimalsHelicobacter InfectionsHelicobacter pyloriHumansPhytotherapySpicesOils, VolatileAnti-inflammatoryCancerGastricHelicobacterH pyloriStomachUlcer

Identifiers

PMID25799054
PMCPMC4465045

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.